CBC-HITES

Chicago, US · In person · Biotech, Healthtech, Medtech · Pre-seed

Terms checked 6 Oct 2026 against the official page.

CBC-HITES is a proof-of-concept biopharma and health technology commercialization program providing Chicagoland academic researchers up to $75,000 in direct costs, industry mentorship, and project management to translate scientific discoveries into biomedical applications.

The terms

Investment
$75k (checked 6 Oct 2026)
Equity
No equity
Program length
12 months (checked 6 Oct 2026)
Format
In person
Applications close
5 May 2026 (checked 6 Oct 2026)

Official page

Founders also compare